Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Marriott

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
The Journal of Antimicrobial Chemotherapy|November 20, 2018
Population pharmacokinetics of ribavirin in lung transplant recipients and examination of current and alternative dosing regimensEliza Milliken, Auke E S de Zwart, Jan-Willem C Alffenaar, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2022
<i>Wolbachia</i> depletion blocks transmission of lymphatic filariasis by preventing chitinase-dependent parasite exsheathmentShannon Quek, Darren A N Cook, Yang Wu, et al.
British Journal of Clinical Pharmacology|March 26, 2021
Are vancomycin dosing guidelines followed? A mixed methods study of vancomycin prescribing practicesJane E Carland, Sophie L Stocker, Melissa T Baysari, et al.
Therapeutic Drug Monitoring|December 9, 2021
Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyStephanie E Reuter, Sophie L Stocker, Jan-Willem C Alffenaar, et al.
Mycoses|November 13, 2020
Risk factors for candidaemia: A prospective multi-centre case-control studyCaitlin Livia Keighley, Alun Pope, Deborah J E Marriott, et al.
Thrombosis and Haemostasis|August 30, 2024
Handheld Point-of-Care Devices for Snakebite Coagulopathy: A Scoping ReviewMichael Abouyannis, Amy E Marriott, Emma Stars, et al.
Clinical Pharmacology and Therapeutics|November 15, 2020
Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series AnalysisSophie L Stocker, Jane E Carland, Stephanie E Reuter, et al.
BMJ Global Health|March 14, 2024
African polyvalent antivenom can maintain pharmacological stability and ability to neutralise murine venom lethality for decades post-expiry: evidence for increasing antivenom shelf life to aid in alleviating chronic shortagesGabriela Solano, Sinead Cunningham, Rebecca J Edge, et al.
Journal of Medicinal Chemistry|April 9, 2026
Identification of DC-174 as a Novel Hydroxamic Precandidate for the Development of an Oral Snakebite TreatmentDaniel J W Chong, Laura-Oana Albulescu, Adam Westhorpe, et al.
Frontiers in Microbiology|July 10, 2023
Dirofilariasis mouse models for heartworm preclinical researchA E Marriott, J L Dagley, S Hegde, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|November 20, 2018
Population pharmacokinetics of ribavirin in lung transplant recipients and examination of current and alternative dosing regimensEliza Milliken, Auke E S de Zwart, Jan-Willem C Alffenaar, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2022
<i>Wolbachia</i> depletion blocks transmission of lymphatic filariasis by preventing chitinase-dependent parasite exsheathmentShannon Quek, Darren A N Cook, Yang Wu, et al.
British Journal of Clinical Pharmacology|March 26, 2021
Are vancomycin dosing guidelines followed? A mixed methods study of vancomycin prescribing practicesJane E Carland, Sophie L Stocker, Melissa T Baysari, et al.
Therapeutic Drug Monitoring|December 9, 2021
Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement From the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyStephanie E Reuter, Sophie L Stocker, Jan-Willem C Alffenaar, et al.
Mycoses|November 13, 2020
Risk factors for candidaemia: A prospective multi-centre case-control studyCaitlin Livia Keighley, Alun Pope, Deborah J E Marriott, et al.
Thrombosis and Haemostasis|August 30, 2024
Handheld Point-of-Care Devices for Snakebite Coagulopathy: A Scoping ReviewMichael Abouyannis, Amy E Marriott, Emma Stars, et al.
Clinical Pharmacology and Therapeutics|November 15, 2020
Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series AnalysisSophie L Stocker, Jane E Carland, Stephanie E Reuter, et al.
BMJ Global Health|March 14, 2024
African polyvalent antivenom can maintain pharmacological stability and ability to neutralise murine venom lethality for decades post-expiry: evidence for increasing antivenom shelf life to aid in alleviating chronic shortagesGabriela Solano, Sinead Cunningham, Rebecca J Edge, et al.
Journal of Medicinal Chemistry|April 9, 2026
Identification of DC-174 as a Novel Hydroxamic Precandidate for the Development of an Oral Snakebite TreatmentDaniel J W Chong, Laura-Oana Albulescu, Adam Westhorpe, et al.
Frontiers in Microbiology|July 10, 2023
Dirofilariasis mouse models for heartworm preclinical researchA E Marriott, J L Dagley, S Hegde, et al.
Pageof 10